Example: Heart Attack

Search clinical trials for: Caspofungin

Total 77 results

NCT03399032

Unknown status

Pharmacokinetics of Caspofungin

Conditions: Septic Shock; Fungal Infection; Critical Illness
NCT03857399

Recruiting

Empiric Therapy of Patients With Persistent Fever and Agranulocytosis Using Caspofungin

Conditions: Fungal Infection
NCT01533558

Completed

Pharmacokinetics of Caspofungin (Cancidas ®) Given Intravenously as Therapy to Patients With an Invasive Fungal Infection in the Intensive Care Unit - a Search for Co-variates

Conditions: Invasive Fungal Infection
NCT02596984

Completed

Evaluation of the Pharmacokinetics of Caspofungin in ICU Patients

Conditions: Shock
NCT02510053

Unknown status

Pharmacokinetics and Pharmacodynamics of Caspofungin (Cancidas ®) and Drug Tolerance of Fungi to Patients With an Invasive Fungal Infection in the Intensive Care Unit

Conditions: Invasive Fungal Infection
NCT01968395

Completed

Pharmacokinetics of Caspofungin After One Dose in Patients With Liver Failure

Conditions: Bacterial Infections and Mycoses; Liver Disease
NCT01318148

Completed

Pharmacokinetic, Safety and Efficacy of Intermittent Application of Caspofungin for Antifungal Prophylaxis

Conditions: Fungal Infection
NCT01499433

Unknown status

Efficacy and Safety of Caspofungin for Invasive Pulmonary Aspergillosis Underlying Chronic Obstructive Pulmonary Disease

Conditions: Invasive Pulmonary Aspergillosis; Chronic Obstructive Pulmonary Disease
NCT03798600

Completed

Pharmacokinetics/Pharmacodynamics (PK/PD) of Caspofungin in Intensive Care Unit (ICU) Patients. An Open Observational Study for Antifungal Treatment's Optimization

Conditions: Critical Illness; Infection
NCT00748345

Completed

Pharmacokinetics of Caspofungin in Burn Patients

Conditions: Thermal Injury
NCT01260974

Unknown status

Caspofungin as Prophylaxis in High Risk Liver Transplantation Recipients

Conditions: Fungemia; Mycoses
NCT00635648

Completed

A Study of Caspofungin Acetate (MK0991) for the Treatment of Esophageal Candidiasis or Invasive Candidiasis in Chinese Adults (MK-0991-066)

Conditions: Fungal Infection
NCT01994096

Completed

Optimal Dosage of Caspofungin in Critically Ill Patients

Conditions: Critically Ill; Suspected Invasive Candidiasis
NCT01062165

Completed

Effect of Weight and/or Obesity on Caspofungin Drug Concentrations

Conditions: Obesity; Fungal Infection
NCT00404092

Completed

Caspofungin Maximum Tolerated Dose in Patients With Invasive Aspergillosis

Conditions: Invasive Aspergillosis
NCT00292071

Completed

Open, Pharmacokinetic Study of Caspofungin Acetate in Immunocompromised Young Children With Febrile Neutropenia (0991-042)

Conditions: Fungal Infection
NCT01045798

Terminated

Pilot Feasibility Study With Patients Who Are at High Risk For Developing Invasive Candidiasis in a Critical Care Setting (MK-0991-067)

Conditions: Invasive Candidiasis
NCT02856178

Withdrawn

Study on Safety and Pharmacokinetics of Intravenous F901318 for Fungal Prophylaxis in AML Patients

Conditions: Pulmonary Aspergillosis - Invasive; Acute Myeloid Leukemia
NCT01165320

Completed

A Study of Caspofungin (MK-0991) in Japanese Children and Adolescents With Documented Candida or Aspergillus Infections (MK-0991-074)

Conditions: Candidiasis, Esophageal; Candidiasis, Invasive; Aspergillosis
NCT00095316

Terminated

Caspofungin Study for Fungal Infections in Adults in Critical Care Settings

Conditions: Candidiasis
NCT00388167

Completed

Acetato de Caspofungin (Cancidas®) in the Treatment of Fungal Infection

Conditions: Candidiasis; Aspergillosis
NCT00379964

Completed

A 28 - 90 Days Study to Evaluate the Safety, Tolerability, and Efficacy of Caspofungin Injection as Empirical Therapy in Indian Adults With Persistent Fever and Neutropenia (0991-053)(COMPLETED)

Conditions: Fungal Infection
NCT00330395

Completed

Open, Pharmacokinetic Study of Caspofungin in Neonates and Infants (0991-058)

Conditions: Candidiasis
NCT00717860

Completed

A Clinical Study of MK0991 (Caspofungin) in Japanese Patients With Deep-seated Candida or Aspergillus Infections (0991-062)(COMPLETED)

Conditions: Fungal Infection
NCT02895529

Terminated

A Study Comparing the Efficacy of Intravenous Followed by Oral Itraconazole With Intravenous Caspofungin For Empiric Antifungal Therapy in Neutropenic Participants With Hematological Malignancy

Conditions: Hematologic Neoplasms